A bumper crop of revisions, including a stronger drug benefit, means the plan you enrolled in for 2024 may not be the best fit next year.
Related Posts
Are You a European in a Housing Crunch? We Want to Hear From You.
To help us report on the housing crisis in Europe, we want to learn about the housing pressures you are dealing with, how they are […]
Commerce Dept. Is on the Front Lines of China Policy
The department has confronted the challenge of China by restricting key exports, a policy that is likely to continue in the Trump administration.
Slightly Higher Inflation Rate Is Expected for October
A fresh Consumer Price Index report could show that inflation, much cooler than in 2022 and 2023, is not fully stamped out.